Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

Clinical trial NCT07095868 · RECRUITING

Trial details

NCT number: NCT07095868
Sponsor: Everest Medicines (Beijing) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Selected Types of Solid Tumor

Start date: 2025-11-17
Primary completion: 2029-11-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.